These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 24550378

  • 21. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
    Girão E, Levin AS, Basso M, Gobara S, Gomes LB, Medeiros EA, Costa SF.
    Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
    [Abstract] [Full Text] [Related]

  • 22. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.
    Fortún J, Muriel A, Martín-Dávila P, Montejo M, Len O, Torre-Cisneros J, Carratalá J, Muñoz P, Fariñas C, Moreno A, Fresco G, Goikoetxea J, Gavaldá J, Pozo JC, Bodro M, Vena A, Casafont F, Cervera C, Silva JT, Aguado JM, Grupo de Estudio de Infección en Pacientes Trasplantados-Grupo de Estudio de Micología Médica (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica), and Red Española de Investigación en Patología Infecciosa.
    Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146
    [Abstract] [Full Text] [Related]

  • 23. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J, Caspofungin Invasive Candidiasis Study Group.
    N Engl J Med; 2002 Dec 19; 347(25):2020-9. PubMed ID: 12490683
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.
    Glöckner A.
    Eur J Med Res; 2011 Apr 28; 16(4):167-79. PubMed ID: 21486731
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
    Cornely OA, Vazquez J, De Waele J, Betts R, Rotstein C, Nucci M, Pappas PG, Ullmann AJ.
    Mycoses; 2014 Feb 28; 57(2):79-89. PubMed ID: 23786573
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q, Lin MH, Chen ML, Liu ZY, Chai D, Wang R.
    Chin Med J (Engl); 2012 Jan 28; 125(2):345-51. PubMed ID: 22340571
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.
    Tsekoura M, Ioannidou M, Pana ZD, Haidich AB, Antachopoulos C, Iosifidis E, Kolios G, Roilides E.
    Pediatr Infect Dis J; 2019 Jan 28; 38(1):42-49. PubMed ID: 29596219
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Undiagnosed invasive candidiasis: incorporating non-culture diagnostics into rational prophylactic and preemptive antifungal strategies.
    Clancy CJ, Nguyen MH.
    Expert Rev Anti Infect Ther; 2014 Jul 28; 12(7):731-4. PubMed ID: 24850393
    [Abstract] [Full Text] [Related]

  • 33. [Tolerance of caspofungin in intensive care unit: a prospective study].
    Constantin JM, Roszyk L, Guerin R, Bannier F, Chartier C, Perbet S, Futier E, Cayot-Constantin S, Sapin V, Bazin JE.
    Ann Fr Anesth Reanim; 2008 Oct 28; 27(10):819-24. PubMed ID: 18835682
    [Abstract] [Full Text] [Related]

  • 34. Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.
    Playford EG, Lipman J, Jones M, Lau AF, Kabir M, Chen SC, Marriott DJ, Seppelt I, Gottlieb T, Cheung W, Iredell JR, McBryde ES, Sorrell TC.
    Clin Infect Dis; 2016 Dec 01; 63(11):1463-1469. PubMed ID: 27601224
    [Abstract] [Full Text] [Related]

  • 35. Low Caspofungin Exposure in Patients in Intensive Care Units.
    van der Elst KC, Veringa A, Zijlstra JG, Beishuizen A, Klont R, Brummelhuis-Visser P, Uges DR, Touw DJ, Kosterink JG, van der Werf TS, Alffenaar JC.
    Antimicrob Agents Chemother; 2017 Feb 01; 61(2):. PubMed ID: 27855112
    [Abstract] [Full Text] [Related]

  • 36. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
    Bailly S, Leroy O, Azoulay E, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Timsit JF, AmarCAND2 Study Group.
    J Infect; 2017 Apr 01; 74(4):408-417. PubMed ID: 28104387
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
    Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, Green M, Nania JJ, Bourque MR, Wise BA, Strohmaier KM, Taylor AF, Kartsonis NA, Chow JW, Arndt CA, DePauw BE, Walsh TJ, Caspofungin Pediatric Study Group.
    Pediatr Infect Dis J; 2010 May 01; 29(5):415-20. PubMed ID: 20431381
    [Abstract] [Full Text] [Related]

  • 40. Double-blind active-control trials: beware the comparator you keep.
    Dinubile MJ.
    Clin Infect Dis; 2008 Oct 15; 47(8):1064-7. PubMed ID: 18781878
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.